FRMD7 Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13371a
Background:
Mutations in this gene are associated with X-linkedcongenital nystagmus.
Other Names:
FERM domain-containing protein 7, FRMD7
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13371a was selected from the N-term region of FRMD7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: FRMD7
Gene ID: 90167
Primary Accession: Q6ZUT3
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Mutations in this gene are associated with X-linkedcongenital nystagmus.
Other Names:
FERM domain-containing protein 7, FRMD7
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13371a was selected from the N-term region of FRMD7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: FRMD7
Gene ID: 90167
Primary Accession: Q6ZUT3
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review